Add Company
Join Now

MoonLake Immunotherapeutics (NASDAQ MLTX) Revenue and Competitors

License our Company Data API

Zug, Switzerland

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MoonLake Immunotherapeutics (NASDAQ MLTX)'s estimated annual revenue is currently $10.4M per year.(i)
  • MoonLake Immunotherapeutics (NASDAQ MLTX)'s estimated revenue per employee is $155,000

Employee Data

  • MoonLake Immunotherapeutics (NASDAQ MLTX) has 67 Employees.(i)
  • MoonLake Immunotherapeutics (NASDAQ MLTX) grew their employee count by 81% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$16.1M10428%N/AN/A
#2
$37.4M511-2%$250.2MN/A
#3
$60.3M389-5%N/AN/A
#4
$31.8M20522%N/AN/A
#5
$1.9M120%N/AN/A
#6
$2.5M16-43%N/AN/A
#7
$7.9M512%N/AN/A
#8
$1.1M717%N/AN/A
#9
$0.6M40%N/AN/A
#10
$10.4M6781%N/AN/A
Add Company

What Is MoonLake Immunotherapeutics (NASDAQ MLTX)?

MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

keywords:N/A

N/A

Total Funding

67

Number of Employees

$10.4M

Revenue (est)

81%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.8M67-3%N/A
#2
N/A6851%N/A
#3
$13.7M68-1%N/A
#4
$12.5M695%N/A
#5
$13.6M72-18%N/A